Washington, D.C. 20549
If any of the securities
being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of
1933, check the following box. x
If this Form is filed to
register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list
the Securities Act registration statement number of the earlier effective registration statement for the same offering. ¨
If this Form is a post-effective
amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration
statement number of the earlier effective registration statement for the same offering. ¨
If this Form is a post-effective
amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration
statement number of the earlier effective registration statement for the same offering. ¨
If delivery of the prospectus
is expected to be made pursuant to Rule 434, check the following box. ¨
Indicate by check mark whether
the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging
growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting
company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.:
If an emerging growth company,
indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ¨
PART II
Information Not Required In Prospectus
Item 31. Other Expenses of Issuance and Distribution.
The following is a statement
of estimated expenses in connection with the offering described in this registration statement. All expenses incurred with respect to
the registration of the Common Stock will be borne by us. All amounts are estimates except the SEC registration fee.
|
|
Amount to be Paid
|
|
SEC Registration Fee
|
|
$
|
9,800
|
|
Legal Fees and Expenses*
|
|
$
|
300,000.00
|
|
Accounting Fees and Expenses*
|
|
$
|
25,000.00
|
|
Total
|
|
$
|
334,800
|
|
|
*
|
Estimated solely for the purpose of this Item. Actual expenses
may vary.
|
Item 32. Sales to Special Parties.
Not applicable.
Item 33. Recent Sales of Unregistered Securities.
Not applicable.
Item 34. Indemnification of Directors and
Officers.
The MGCL permits a Maryland
corporation to include in its charter a provision limiting the liability of its directors and officers to the corporation and its stockholders
for money damages except for liability resulting from (a) actual receipt of an improper benefit or profit in money, property or services
or (b) active and deliberate dishonesty established by a final judgment as being material to the cause of action. The Company’s
Charter contains such a provision which eliminates such liability to the maximum extent permitted by Maryland law.
The Company’s Charter
requires it, to the maximum extent permitted by Maryland law, to indemnify and to pay or reimburse reasonable expenses in advance of final
disposition of a proceeding to our present and former directors and officers, whether serving us or any other entity at our request, from
and against any claim or liability to which such person may become subject or which such person may incur by reason of his or her service
in any such capacity. The bylaws of the Company establish certain procedures for indemnification and advancement of expenses pursuant
to Maryland law and the Company’s Charter.
The MGCL requires a
corporation (unless its charter provides otherwise, which the our Charter does not) to indemnify a director or officer who has been
successful, on the merits or otherwise, in the defense of any proceeding to which he or she is made, or threatened to be made, a
party by reason of his or her service in that capacity. The MGCL permits a corporation to indemnify its present and former directors
and officers, among others, against judgments, penalties, fines, settlements and reasonable expenses actually incurred by them in
connection with any proceeding to which they may be made, or threatened to be made, a party by reason of their service in those or
other capacities unless it is established that (a) the act or omission of the director or officer was material to the matter
giving rise to the proceeding and (i) was committed in bad faith or (ii) was the result of active and deliberate
dishonesty, (b) the director or officer actually received an improper personal benefit in money, property or services, or
(c) in the case of any criminal proceeding, the director or officer had reasonable cause to believe that the act or omission
was unlawful. However, under the MGCL, a Maryland corporation may not indemnify for an adverse judgment in a suit by or in the right
of the corporation or for a judgment of liability on the basis that personal benefit was improperly received, unless in either case
a court orders indemnification, and then only for expenses. In addition, the MGCL permits a corporation to advance reasonable
expenses to a director or officer upon the corporation’s receipt of (x) a written affirmation by the director or officer
of his or her good faith belief that he or she has met the standard of conduct necessary for indemnification by the corporation and
(y) a written undertaking by him or her or on his or her behalf to repay the amount paid or reimbursed by the corporation if it
shall ultimately be determined that the standard of conduct was not met.
The Company has entered into
indemnification agreements with certain of its directors and officers. Under the indemnification agreements, the Company will indemnify
each indemnitee to the maximum extent permitted by Maryland law for liabilities and expenses arising out of the indemnitee’s service
to the Company or other entity for which such indemnitee is or was serving at the request of the Company. The indemnification agreements
also provide (a) for the advancement of expenses by the Company, subject to certain conditions, (b) a procedure for determining
an indemnitee’s entitlement to indemnification and (c) for certain remedies for the indemnitee. In addition, the indemnification
agreements require the Company to use its reasonable best efforts to obtain directors and officers liability insurance on terms and conditions
deemed appropriate by the Board.
The Company maintains insurance
for its directors and officers against certain liabilities, including liabilities under the Securities Act, under insurance policies,
the premiums of which are paid by the Company. The effect of these insurance policies is to indemnify any directors or officers of the
Company against expenses, judgments, attorneys’ fees and other amounts paid in settlements incurred by a director or officer upon
a determination that such person acted in accordance with the requirements of such insurance policy.
Item 35. Treatment of Proceeds from Stock
Being Registered.
None.
Item 36. Financial Statements and Exhibits.
(a) Financial
Statements. The financial statements set forth in the documents that are incorporated by reference as part of the prospectus included
in this registration statement are set forth in the section of the prospectus entitled “Incorporation by Reference.”
(b) Exhibits.
The list of exhibits filed with or incorporated by reference in this registration statement is set forth in the Exhibit Index below.
Item 37. Undertakings.
(i) The undersigned
registrant hereby undertakes:
(A)
To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:
(1)
To include any prospectus required by section 10(a)(3) of the Securities Act.
(2) To reflect
in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective
amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration
statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities
offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range
may be reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in volume
and price represent no more than a 20% change in the maximum aggregate offering price set forth in the “Calculation of Registration
Fee” table in the effective registration statement.
(3)
To include any material information with respect to the plan of distribution not previously disclosed in the registration statement
or any material change to such information in the registration statement.
(B) That,
for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new
registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to
be the initial bona fide offering thereof.
(C) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at
the termination of the offering.
(D) That, for
the purpose of determining liability under the Securities Act to any purchaser, each prospectus filed pursuant to Rule 424(b) as
part of the registration statement relating to the offering, other than a registration statement relying on Rule 430B or other than
a prospectus filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the
date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is
part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement
or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first
use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement
or made in any such document immediately prior to such date of first use.
(E) That, for the
purpose of determining liability of the registrant under the Securities Act to any purchaser in the initial distribution of the securities,
in a primary offering of securities pursuant to this registration statement, regardless of the underwriting method used to sell the securities
to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned
registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:
(1) any preliminary
prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424;
(2) any free
writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned
registrant;
(3) the portion
of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its
securities provided by or on behalf of the undersigned registrant; and
(4) any other
communication that is an offer in the offering made by the undersigned registrant to the purchaser.
(ii) Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of
the registrant pursuant to the foregoing provisions and otherwise, the registrant has been advised that in the opinion of the SEC such
indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim
for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer
or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer
or controlling person in connection with securities being registered, the registrant will, unless in the opinion of its counsel the matter
has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by
it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.
POWER OF ATTORNEY
Each person whose signature
appears below appoints Deric S. Eubanks as his or her true and lawful attorney-in-fact and agents, with full power of substitution and
resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including
post-effective amendments) to this registration statement and to file the same, with all exhibits thereto, and all other documents in
connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agents full power and authority
to do and perform each and every act and thing requisite and necessary to be done, as fully to all intents and purposes as he or she might
or would do in person, hereby ratifying and confirming all that said attorney-in-fact and agents or any of them or their or his substitute
or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements
of the Securities Exchange Act of 1933, this registration statement has been signed below by the following persons on behalf of the Company
and in the capacities and on the dates indicated.
Name
|
|
Title
|
|
Date
|
|
|
|
|
|
/s/
J. Robison Hays, III
|
|
Chief
Executive Officer and President; Director (Principal Executive Officer)
|
|
September
24, 2021
|
J.
Robison Hays, III
|
|
|
|
|
|
|
|
/s/
Alex Rose
|
|
Executive
Vice President, General Counsel and Secretary
|
|
September
24, 2021
|
Alex
Rose
|
|
|
|
|
|
|
|
/s/
Deric S. Eubanks
|
|
Chief
Financial Officer and Treasurer (Principal Financial Officer)
|
|
September
24, 2021
|
Deric
S. Eubanks
|
|
|
|
|
|
|
|
/s/
Jeremy J. Welter
|
|
Chief
Operating Officer
|
|
September
24, 2021
|
Jeremy
J. Welter
|
|
|
|
|
|
|
|
|
|
|
|
/s/
Mark L. Nunneley
|
|
Chief
Accounting Officer (Principal Accounting Officer)
|
|
September
24, 2021
|
Mark
L. Nunneley
|
|
|
|
Name
|
|
Title
|
|
Date
|
|
|
|
|
|
/s/
Monty J. Bennett
|
|
Director
and Chairman of the Board
|
|
September
24, 2021
|
Monty
J. Bennett
|
|
|
|
|
|
|
|
/s/
Benjamin J. Ansell, MD
|
|
Director
|
|
September
24, 2021
|
Benjamin
J. Ansell, MD
|
|
|
|
|
|
|
|
/s/
Amish V. Gupta
|
|
Lead
Director
|
|
September
24, 2021
|
Amish
V. Gupta
|
|
|
|
|
|
|
|
/s/
Kamal Jafarnia
|
|
Director
|
|
September
24, 2021
|
Kamal
Jafarnia
|
|
|
|
|
|
|
|
/s/
Frederick J. Kleisner
|
|
Director
|
|
September
24, 2021
|
Frederick
J. Kleisner
|
|
|
|
|
|
|
|
/s/
Sheri L. Pantermuehl
|
|
Director
|
|
September
24, 2021
|
Sheri
L. Pantermuehl
|
|
|
|
|
|
|
|
/s/
Alan L. Tallis
|
|
Director
|
|
September
24, 2021
|
Alan
L. Tallis
|
|
|
|